In particular, ~77% of those who developed RA within the Healthfair cohort did not have dual RF-IgA and RF-IgM positivity, and an additional subset with incident RA were negative for both RF’s and/or had anti-CCP3 levels <=60. Here, CD79A is linked to rheumatoid arthritis.